| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
3
5
5
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 17.43 | 15.71 | 1.72 |
| Stocks | 40.7 | 0.0 | 40.7 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 1.16 | 0.35 | 0.81 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 57.68 | 0.93 | 56.74 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.03 | 0.0 | 0.03 |
Updated 11.30.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 11.30.2012
| % Net Assets | |
|---|---|
| GMO US Flexible Equities VI | 42.62 |
| GMO Intl Intrinsic Value IV | 30.68 |
| GMO International Growth Equity IV | 10.42 |
| GMO Currency Hedged Intl Equity III | 7.47 |
| GMO US Core Equity VI | 4.88 |
| GMO Emerging Markets VI | 2.04 |
| GMO Flexible Equities VI | 1.88 |
